关于在状细胞疾病中怀孕的全面审查
Tejas Shegekar1, Sandhya Pajai1
1Obstetrics and Gynecology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.
Cureus
|August 1, 2023
概括
患有状细胞疾病 (SCD) 的怀孕增加了母亲和婴儿的风险. 包括怀孕前,产前,产内和产后策略在内的综合护理对于在怀孕期间管理SCD并发症至关重要.
科学领域:
- 血液学 血液学 血液学
- 产科和妇科 产科和妇科
- 遗传学 遗传学是一种遗传学.
背景情况:
- 状细胞血红蛋白病是一种遗传性血液疾病,状细胞疾病 (SCD) 是全球最常见的疾病.
- 怀孕加剧SCD风险,导致潜在的并发症,如血管闭塞危机,血栓栓塞事件,以及对母亲和胎儿的不良后果.
- 妊娠中SCD的有效管理对于母亲和儿童的健康结果至关重要.
研究的目的:
- 审查和倡导对患有状细胞疾病的孕妇进行综合管理策略.
- 突出整体护理在整个怀孕连续性的重要性,从怀孕前到产后.
- 通知医疗保健提供者关于当前的指导方针和研究管理SCD在怀孕.
主要方法:
- 文献综述,重点关注状细胞病患者的孕前,产前,产内和产后护理.
- 对当前指导方针的分析和关于在怀孕期间管理SCD并发症的研究.
- 强调基因查,风险意识和多学科护理方法.
主要成果:
- 孕前护理包括遗传查,咨询和心理社会评估.
- 加强产前护理包括例行监测,预防药物 (阿司匹林,铁,叶酸) 和超声监测.
- 产内护理建议机构分娩,而产后护理强调监测,输血支持和新生儿查.
结论:
- 涵盖怀孕所有阶段的结构化,多学科的方法对于优化状细胞疾病的结果至关重要.
- 早期诊断,遗传咨询和积极管理可以减轻严重的并发症.
- 为了改善受SCD影响的孕妇的孕产妇和胎儿健康,需要继续研究和遵守最新的指南.
更多相关视频
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.6K
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
9.9K
相关概念视频
Pathophysiology of Diabetes
993
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
993
Multiple Allele Traits
34.3K
The Concept of Multiple Allelism
34.3K
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Disorders of Erythrocytes
994
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
994
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
